Sastasundar Ventures Limited (NSE:SASTASUNDR)
292.80
+1.70 (0.58%)
Jun 24, 2025, 2:30 PM IST
Sastasundar Ventures Revenue
In the fiscal year ending March 31, 2025, Sastasundar Ventures had annual revenue of 11.71B INR, down -18.20%. Sastasundar Ventures had revenue of 3.07B in the quarter ending March 31, 2025, a decrease of -4.03%.
Revenue
11.71B
Revenue Growth
-18.20%
P/S Ratio
0.79
Revenue / Employee
12.44M
Employees
941
Market Cap
9.26B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 11.71B | -2.61B | -18.20% |
Mar 31, 2024 | 14.31B | 3.71B | 34.95% |
Mar 31, 2023 | 10.61B | 4.22B | 66.06% |
Mar 31, 2022 | 6.39B | 879.80M | 15.98% |
Mar 31, 2021 | 5.51B | 1.64B | 42.39% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 272.67B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Mankind Pharma | 122.07B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 129.65B |